Assignee
ACORDA THERAPEUTICS INC
US·59 granted patents·83 pending applications·246 citations·filing 1994–2023
Top patents by PatentIndex Score
142 records- 0194US8007826B2Sustained release aminopyridine compositionACORDA THERAPEUTICS INC·Filed 2004·Granted Aug 30, 2011·29 cites·41 claims
- 0292US9198951B2Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failureACORDA THERAPEUTICS INC·Filed 2013·Granted Dec 1, 2015·10 cites·5 claims
- 0392US8354437B2Method of using sustained release aminopyridine compositionsACORDA THERAPEUTICS INC·Filed 2005·Granted Jan 15, 2013·13 cites·40 claims
- 0490US9289501B2Carbonate prodrugs and methods of using the sameACORDA THERAPEUTICS INC·Filed 2015·Granted Mar 22, 2016·6 cites·10 claims
- 0590US2023390261A1Sustained Release Aminopyridine CompositionACORDA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0689US9683000B2Carbonate prodrugs and methods of using the sameACORDA THERAPEUTICS INC·Filed 2016·Granted Jun 20, 2017·5 cites·1 claims
- 0788US8993545B2Carbonate prodrugs and methods of using the sameACORDA THERAPEUTICS INC·Filed 2014·Granted Mar 31, 2015·6 cites·12 claims
- 0888US2023133230A1Sustained Release Aminopyridine CompositionACORDA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0987US9981998B2Water-soluble acetaminophen analogsACORDA THERAPEUTICS INC·Filed 2016·Granted May 29, 2018·4 cites·24 claims
- 1086US11141467B2Methods of reducing extravasation of inflammatory cellsACORDA THERAPEUTICS INC·Filed 2017·Granted Oct 12, 2021·2 cites·4 claims
- 1186US9956266B2Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failureACORDA THERAPEUTICS INC·Filed 2015·Granted May 1, 2018·2 cites·12 claims
- 1285US2022296577A1Sustained release aminopyridine compositionACORDA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1384US2024041850A1Methods of Using Sustained Release Aminopyridine CompositionsACORDA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1483US9549893B2Compositions and kits for the removal of irritating compounds from bodily surfacesACORDA THERAPEUTICS INC·Filed 2014·Granted Jan 24, 2017·3 cites·10 claims
- 1583US7662772B2Methods for treating congestive heart failureACORDA THERAPEUTICS INC·Filed 2003·Granted Feb 16, 2010·13 cites·15 claims
- 1683US7485295B2Compositions and methods of using chondroitinase ABCI mutantsACORDA THERAPEUTICS INC·Filed 2006·Granted Feb 3, 2009·4 cites·13 claims
- 1783US2022040161A1Sustained release aminopyridine compositionACORDA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1882US9024055B2Acetaminophen conjugates, compositions and methods of use thereofACORDA THERAPEUTICS INC·Filed 2012·Granted May 5, 2015·5 cites·9 claims
- 1981US9410141B2Compositions and methods of using chondroitinase ABCI mutantsACORDA THERAPEUTICS INC·Filed 2015·Granted Aug 9, 2016·2 cites·16 claims
- 2081US7722864B2Compositions and methods of using chondroitinase ABCI mutantsACORDA THERAPEUTICS INC·Filed 2007·Granted May 25, 2010·3 cites·32 claims
- 2181US7037888B1Methods for treating muscle diseases and disordersACORDA THERAPEUTICS INC·Filed 1995·Granted May 2, 2006·60 cites·36 claims
- 2280US9757429B2Methods for detecting cardiac damageACORDA THERAPEUTICS INC·Filed 2016·Granted Sep 12, 2017·2 cites·11 claims
- 2380US8026213B2Methods for treating muscle diseases and disordersACORDA THERAPEUTICS INC·Filed 2010·Granted Sep 27, 2011·3 cites·1 claims
- 2480US2021205282A1Sustained release aminopyridine compositionACORDA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2579US9750707B2Methods and compositions for administration of TRPV1 agonistsACORDA THERAPEUTICS INC·Filed 2014·Granted Sep 5, 2017·2 cites·84 claims
- 2679US7731956B2Compositions and methods of using chondroitinase ABCI mutantsACORDA THERAPEUTICS INC·Filed 2008·Granted Jun 8, 2010·2 cites·13 claims
- 2778US9102930B2Compositions and methods of using chondroitinase ABCI mutantsACORDA THERAPEUTICS INC·Filed 2013·Granted Aug 11, 2015·2 cites·21 claims
- 2878US7968089B2Proteoglycan degrading mutants for the treatment of CNSACORDA THERAPEUTICS INC·Filed 2008·Granted Jun 28, 2011·2 cites·34 claims
- 2978US2020113883A1Durable treatment with 4-aminopyridine in patients with demyelinationACORDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3078US2020113882A1Use of 4-Aminopyridine to Improve Neuro-Cognitive and/or Neuro-Psychiatric Impairment in Patients with Demyelinating and Other Nervous System ConditionsACORDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3177US9329171B2Methods for detecting cardiac damageACORDA THERAPEUTICS INC·Filed 2014·Granted May 3, 2016·2 cites·11 claims
- 3277US2020368217A1Sustained release aminopyridine compositionACORDA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3376US10065999B2Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by NRG-2ACORDA THERAPEUTICS INC·Filed 2014·Granted Sep 4, 2018·1 cites·6 claims
- 3476US7968678B2Glial mitogenic factors, their preparation and useACORDA THERAPEUTICS INC·Filed 2007·Granted Jun 28, 2011·1 cites·7 claims
- 3576US2019134016A1Methods for treating an impairment in gait and/or balance in patients with multiple sclerosis using an aminopyridineACORDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3675US11021498B2Water-soluble acetaminophen analogsACORDA THERAPEUTICS INC·Filed 2019·Granted Jun 1, 2021·0 cites·1 claims
- 3775US10717775B2Methods for cardiomyocyte survival, proliferation or differentiation by NRG-2ACORDA THERAPEUTICS INC·Filed 2018·Granted Jul 21, 2020·0 cites·9 claims
- 3875US7718606B2Methods for treating muscle diseases and disordersACORDA THERAPEUTICS INC·Filed 2008·Granted May 18, 2010·1 cites·12 claims
- 3975US6890751B2NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methodsACORDA THERAPEUTICS INC·Filed 2001·Granted May 10, 2005·4 cites·15 claims
- 4075US2019022076A1Sustained release aminopyridine compositionACORDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4175US2011166068A1Therapeutic Dosing of a Neuregulin or a Subsequence Thereof for Treatment or Pro-phylaxis of Heart FailureACORDA THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 4275US2019247379A1Use of 4-Aminopyridine to Improve Neuro-Cognitive and/or Neuro-Psychiatric Impairment in Patients with Demyelinating and Other Nervous System ConditionsACORDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4374US10232016B2Methods for treating congestive heart failureACORDA THERAPEUTICS INC·Filed 2015·Granted Mar 19, 2019·1 cites·25 claims
- 4474US7115554B1Methods of increasing myotube formation or survival or muscle cell mitogenesis differentiation or survival using neuregulin GGF IIIACORDA THERAPEUTICS INC·Filed 1994·Granted Oct 3, 2006·19 cites·35 claims
- 4574US2018153869A1Sustained release aminopyridine compositionACORDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4674US2019314350A1Methods of using sustained release aminopyridine compositionsACORDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4773US9918973B2Sustained release aminopyridine compositionACORDA THERAPEUTICS INC·Filed 2017·Granted Mar 20, 2018·0 cites·12 claims
- 4873US9272015B2Method for achieving desired glial growth factor 2 plasma levelsACORDA THERAPEUTICS INC·Filed 2013·Granted Mar 1, 2016·1 cites·13 claims
- 4973US2020230121A1Methods for treating an impairment in gait and/or balance in patients with multiple sclerosis using an aminopyridineACORDA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 5073US2019015399A1Use of 4-Aminopyridine to Improve Neuro-Cognitive and/or Neuro-Psychiatric Impairment in Patients with Demyelinating and Other Nervous System ConditionsACORDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
Showing the top 50 of 142 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when ACORDA THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →